Skip to content
POM-V Prescription Required Companion Animal

Banacep Vet 20 mg Film-coated Tablet for Dogs

Active ingredient: Benazepril Hydrochloride

Form

Tablet

Species

Dogs

Manufacturer

Laboratorios Calier, S.A.

VMD MA No.

20634/3005

What it's used for

Dogs: Treatment of congestive heart failure. Cats: Reduction of proteinuria associated with chronic kidney disease.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Benazepril Hydrochloride

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Banacep Vet 20 mg Film-coated Tablet for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Dogs:
Treatment of congestive heart failure.
Cats:
Reduction of proteinuria associated with chronic kidney disease.
The veterinary medicinal product should be given orally once daily, with or without food.
The duration of treatment is unlimited.
The veterinary medicinal product should be administered at a minimum dose of 0.25 mg
(range 0.25-
0.5) benazepril hydrochloride/kg body weight once daily, according to the following table:
Banacep Vet 20 mg
Film-Coated Tablet
Weight of dog (kg)Standard doseDouble dose>20 - 400.5 tablet1 tablet40 - 801 tablet2 tablet
The dose may be doubled, still administered once daily, to a minimum dose of 0.5 mg/kg
(range 0.5 – 1.0), if judged clinically necessary and advised by the veterinary surgeon.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Do not use in cases of hypotension, hypovolaemia, hyponatraemia or acute renal failure.
Do not use in cases of cardiac output failure, due to aortic or pulmonary stenosis.
Do not use during pregnancy or lactation (see section 3.7).
Undetermined frequency (cannot
be estimated from the available
data):
Vomiting
Incoordination
Fatigue
Elevated creatinine*
*In dogs with chronic kidney disease, at the start of therapy.
A moderate increase in plasma creatinine concentrations following administration of ACE
inhibitors is compatible with the reduction in glomerular hypertension induced by these
agents and is therefore not necessarily a reason to stop therapy in the absence of other
signs.
In double-blind clinical trials in dogs with congestive heart failure, the veterinary medicinal
product was well tolerated with an incidence of adverse reactions lower than observed in
placebo-treated dogs.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder <or its local representative> or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
None

Special precautions for safe use in the target species:
No evidence of renal toxicity to benazepril has been observed in dogs. However, as is
routine in cases of chronic renal insufficiency, it is recommended to monitor plasma
creatinine, urea and erythrocyte counts during therapy.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Wash hands after use.
In case of accidental oral ingestion, seek medical advice immediately and show the label
or the package leaflet to the physician.
Pregnant women should take special care to avoid accidental oral exposure, because
angiotensin converting enzyme (ACE) inhibitors have been found to affect the unborn
child during pregnancy in humans.
Special precautions for the protection of the environment:
Not applicable.
In dogs with congestive heart failure, the veterinary medicinal product has been given in
combination with digoxin, diuretics, pimobendan and anti-arrhythmic veterinary medicinal
products without demonstrable adverse interactions.
In humans, the combination of ACE inhibitors and Non-Steroidal Anti-Inflamatory Drugs
(NSAIDs) can lead to reduced anti-hypertensive efficacy or impaired renal function. The
combination of the veterinary medicinal product and other anti-hypertensive agents (e.g.
calcium channel blockers, or diuretics), anaesthetics or sedatives may lead to
additive hypotensive effects. Therefore, concurrent use of NSAIDs or other medications
with a hypotensive effect should be considered with care. Renal function and signs of
hypotension (lethargy, weakness etc) should be monitored closely and treated as
necessary.
Interactions with potassium preserving diuretics like spironolactone, triamterene or
amiloride cannot be ruled out. It is recommended to monitor plasma potassium levels
when using the veterinary medicinal product in combination with a potassium sparing
diuretic because of the risk of hyperkalaemia.
Do not store above 25°C.
Store in a dry place
Protect from light
Return any halved tablet to the open blister space and use within 1 day. The blister pack
should be inserted back into the carboard box.
Not applicable.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.